Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?

Fahmideh, F; Marchesi, N; Campagnoli, L I M; Landini, L; Caramella, C; Barbieri, A; Govoni, S; Pascale, A

Fahmideh, F; Marchesi, N; Campagnoli, L I M; Landini, L; Caramella, C; Barbieri, A; Govoni, S; Pascale, A.

Afiliación

Fahmideh F; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Marchesi N; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Campagnoli LIM; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Landini L; Bausch & Lomb-Iom S.p.A, Vimodrone (Milan), Italy.
Caramella C; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Barbieri A; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Govoni S; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.
Pascale A; Department of Drug Sciences, Pharmacology Section, University of Pavia, Pavia, Italy.

Front Pharmacol ; 13: 951833, 2022.

Article en En | MEDLINE | ID: mdl-36046820

Palabras clave

ELAV proteins; PKC; VEGF; diabetic retinopathy; endothelial cells; hyperglycemia; troxerutin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google